3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with dinoprost in 1 studies
Studies (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Trials (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Recent Studies (post-2010) (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Studies (dinoprost) | Trials (dinoprost) | Recent Studies (post-2010) (dinoprost) |
---|---|---|---|---|---|
36 | 1 | 1 | 11,554 | 940 | 1,936 |
Protein | Taxonomy | 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid (IC50) | dinoprost (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.0025 | |
Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.0713 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.14 | |
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.3 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.14 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 4.2 | |
Prostaglandin F2-alpha receptor | Bos taurus (cattle) | 0.14 | |
Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.0139 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.216 | |
Prostaglandin D2 receptor | Homo sapiens (human) | 4.5 | |
Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.287 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beauchamp, MH; Bernier, SG; Chemtob, S; Gobeil, F; Hou, X; Kanai, K; Lepage, G; Morrow, JD; Roberts, LJ; Taber, DF; Varma, DR | 1 |
1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and dinoprost
Article | Year |
---|---|
2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Brain; Calcium; Calcium Channel Blockers; Carbazoles; Dinoprost; Endothelium, Vascular; Enzyme Inhibitors; F2-Isoprostanes; gamma-Linolenic Acid; Humans; In Vitro Techniques; Microcirculation; Prostaglandin Antagonists; Pyridines; Retinal Vessels; Swine; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2001 |